Perfusfind S.L.

Abstract Background: Preventable surgical errors of varying degrees of physical, emotional, and financial harm account for a significant number of adverse events. These errors are frequently tied to systemic problems..

Perfusfind S.L.

Abstract The provision of cardiac surgery services nationwide has been affected by the COVID-19 pandemic. We noticed a high COVID-19 mortality rate in unvaccinated patients who were diagnosed with COVID-19..

Perfusfind S.L.

Abstract Background Machine learning may enhance prediction of outcomes after  (CABG). We sought to develop and validate a dynamic machine learning model to predict CABG outcomes at clinically relevant pre- and..

Perfusfind S.L.

Vídeo con el curso completo del Curso de Ecocardiografía Perioperatoria bajo la dirección de Miguel Ángel García Fernández, Javier Hortal Iglesias y Carolina Cabrera Schulmeyer. La mesa 1 está moderada..

Perfusfind S.L.

Patient with previous COVID 19 and aortopulmonary fistula undergone Right side mini thoracotomy and and aort to lung cavity due to COVID 19 necrosis completely sealed and closed postoperative phase..

Perfusfind S.L.

Patient with one time previous mitral valve replacement due to rheumatismal involvement second time tricuspid valve replacement for severe TR and finally tonight trido Mitral valve cleaning operation with routine..

Perfusfind S.L.

Abstract Background: Patients on direct oral anticoagulants are at high risk of perioperative bleeding complicaapitions. We analyzed the results of intraoperative hemoadsorption (HA) in patients undergoing cardiac surgery who were..

Perfusfind S.L.

Abstract Background Shock severity predicts mortality in patients with cardiogenic shock (CS). We evaluated the association between pre-cannulation Society for Cardiovascular Angiography and Interventions (SCAI) shock classification and mortality among..

Perfusfind S.L.

Abstract Background Minimally invasive extracorporeal circulation (MiECC) is employed as a strategy to attenuate the physiologic disturbance caused by cardiopulmonary bypass. The aim of this study was to compare the..

Perfusfind S.L.

Abstract During a 6 week period beginning early March 2020, 30 patients with severe coronavirus disease 2019 (COVID-19) were supported with venovenous extracorporeal membrane oxygenation (ECMO). This volume increase mandated..

Perfusfind S.L.

Abstract Background Treatment of significant coagulopathic cardiac surgical field bleeding with immediate higher-dose  (PCC) without  (FFP) or  is unexplored. Aims To study characteristics, , and clinical outcomes of patients with significant coagulopathic surgical field..

Perfusfind S.L.

Organizado pela Liga Nacional de Perfusão, o III Interligas de Perfusão visa motivar a produção científica e provocar o desenvolvimento crítico por parte dos ligantes participantes e demais ouvintes. Dessa forma, o evento tem o intuito de unir as ligas..

Perfusfind S.L.

Abstract The implantation of the left ventricular assist device Abbott HeartMate 3TM is being increasingly performed for management of end-stage heart failure. LVAD implantation might be associated with early or..

Perfusfind S.L.

Abstract Mitral valve prolapse (MVP) is the most common primary valvular abnormality, associated with various degrees of incompetent function and sequelae, including heart failure and sudden cardiac death. Recent improvements..

Perfusfind S.L.

Patient with severe AS and bicuspid aortic valve with 100 age undergone AVR and root reconstruction.   Dr.Sam Zeraatian Nejad Davani, CEO of rockingham medical research ADKWA center as well..

Perfusfind S.L.

Abstract Background: This study aimed to estimate the cost-effectiveness of extracorporeal cardiopulmonary resuscitation (ECPR) for in-hospital cardiac arrest treatment. Methods: A decision tree and Markov model were constructed based on current literature...

Perfusfind S.L.

Abstract Left ventricular assist devices (LVADs) are safer and provide better survival and better quality of life than biventricular assist devices (BVADs) but end-stage heart failure often involves both ventricles,..

Perfusfind S.L.

Abstract We describe three successful cases of HeartMate left ventricular assist device (LVAD; Thermo Cardiosystems, Woburn, MA, USA) implantation in patients with end-stage heart failure for long-term circulatory support. Patient..

Perfusfind S.L.

Heart and other visceral harvest for transplantation in patient with extensive type B aortic dissection by subclavian exclusion technique.   Dr.Sam Zeraatian Nejad Davani, CEO of rockingham medical research ADKWA..

Perfusfind S.L.

Heart Harvest for transplantation after complete cardiovascular arrest as well as Brain Death usage criteria and protocol and cannulation technique.   Dr.Sam Zeraatian Nejad Davani, CEO of rockingham medical research..

Perfusfind S.L.

Beating superior cavopulmonary anastomoses in patient with TF and pulmonary atresia and two previous failed shunt.   Dr.Sam Zeraatian Nejad Davani, CEO of rockingham medical research ADKWA center as well..

Perfusfind S.L.

Patient with mega pulmonary artery one variant of TF with absent pulmonary valve and mega pulmonary artery causing compression on trachea.   Dr.Sam Zeraatian Nejad Davani, CEO of rockingham medical..

Perfusfind S.L.

Beating extracardiac fontan operation with just applying partial clamp in patient with previous superior cavopulmonary anastomoses and single ventricle. Off pump fontan ! Our five years of experience in congenital..

Perfusfind S.L.

Patient with blunt chest trauma and LT pulmonary artery thrombosis undergone LT pulmonary artery clot evacuation in the Acute phase and tubular graft anastomoses at the same time lung reperfused..

Perfusfind S.L.

Patient with huge LV aneurysm and HF undergone apical LV aneurysm resection and reconstruction with teflon felt.   Dr.Sam Zeraatian Nejad Davani, CEO of rockingham medical research ADKWA center as..

Perfusfind S.L.

Patient with multiple cardiac fibroma and RVOT obstruction undergone resection and RVOT reconstruction 2 years   Dr.Sam Zeraatian Nejad Davani, CEO of rockingham medical research ADKWA center as well as..

Perfusfind S.L.

Abstract Extracorporeal membrane oxygenation (ECMO) is a treatment that provides hemodynamic or respiratory support to severely critically ill patients. However, ECMO introduces many variables that must be considered for antibiotic..

Perfusfind S.L.

Abstract Out-of-hospital cardiac arrest is a leading cause of mortality with survival rates of less than 10%. In selected patients, survival may be improved via timely application of extracorporeal cardiopulmonary resuscitation (ECPR)...

Perfusfind S.L.

Abstract Introduction Lactate levels have been recognized as a reliable tool for monitoring critically ill patients requiring venoarterial extracorporeal membrane oxygenation (VA ECMO) or venovenous extracorporeal membrane oxygenation (VV ECMO)..

Perfusfind S.L.

Abstract BACKGROUND: Perioperative hemodynamic instability mediated by anaphylaxis is a life-threatening complication in patients undergoing cardiac surgery with cardiopulmonary bypass (CPB). This study aimed to evaluate the effect of clemastine fumarate..